Literature DB >> 21515824

Defective inhibition of B-cell proliferation by Wiskott-Aldrich syndrome protein-deficient regulatory T cells.

Marsilio Adriani1, Krysten A Jones, Toru Uchiyama, Martha R Kirby, Christopher Silvin, Stacie M Anderson, Fabio Candotti.   

Abstract

Wiskott-Aldrich syndrome (WAS) is an inherited immunodeficiency characterized by high incidence of autoantibody-mediated autoimmune complications. Such a feature has been associated with defective suppressor activity of WAS protein-deficient, naturally occurring CD4(+)CD25(+)Foxp3(+) regulatory T cells on responder T cells. However, it remains to be established whether the altered B-cell tolerance reported in WAS patients and Was knockout (WKO) mice is secondary to abnormalities in the direct suppression of B-cell function by nTreg cells or to impaired regulation of T-helper function. Because activated nTreg cells are known to induce granzyme B-mediated B-cell killing, we decided to evaluate the regulatory capabilities of WKO nTregs on B lymphocytes. We found that preactivated WKO nTreg cells failed to effectively suppress B-cell proliferation and that such a defect was associated with reduced killing of B cells and significantly decreased degranulation of granzyme B. Altogether, these results provide additional mechanistic insights into the loss of immune tolerance in WAS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21515824      PMCID: PMC3123025          DOI: 10.1182/blood-2010-12-322834

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Activated CD4+CD25+ T cells selectively kill B lymphocytes.

Authors:  Dong-Mei Zhao; Angela M Thornton; Richard J DiPaolo; Ethan M Shevach
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

2.  WASP confers selective advantage for specific hematopoietic cell populations and serves a unique role in marginal zone B-cell homeostasis and function.

Authors:  Lisa S Westerberg; Miguel A de la Fuente; Fredrik Wermeling; Hans D Ochs; Mikael C I Karlsson; Scott B Snapper; Luigi D Notarangelo
Journal:  Blood       Date:  2008-09-04       Impact factor: 22.113

3.  Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis.

Authors:  Stephanie Humblet-Baron; Blythe Sather; Stephanie Anover; Shirly Becker-Herman; Debora J Kasprowicz; Socheath Khim; Thuc Nguyen; Kelly Hudkins-Loya; Charles E Alpers; Steve F Ziegler; Hans Ochs; Troy Torgerson; Daniel J Campbell; David J Rawlings
Journal:  J Clin Invest       Date:  2007-01-11       Impact factor: 14.808

4.  Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism.

Authors:  David C Gondek; Li-Fan Lu; Sergio A Quezada; Shimon Sakaguchi; Randolph J Noelle
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

5.  Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response.

Authors:  Lisa Westerberg; Malin Larsson; Samantha J Hardy; Carmen Fernández; Adrian J Thrasher; Eva Severinson
Journal:  Blood       Date:  2004-09-21       Impact factor: 22.113

6.  Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome.

Authors:  Marsilio Adriani; Joseph Aoki; Reiko Horai; Angela M Thornton; Akihiro Konno; Martha Kirby; Stacie M Anderson; Richard M Siegel; Fabio Candotti; Pamela L Schwartzberg
Journal:  Clin Immunol       Date:  2007-05-18       Impact factor: 3.969

7.  Opposing effects of PKCtheta and WASp on symmetry breaking and relocation of the immunological synapse.

Authors:  Tasha N Sims; Timothy J Soos; Harry S Xenias; Benjamin Dubin-Thaler; Jake M Hofman; Janelle C Waite; Thomas O Cameron; V Kaye Thomas; Rajat Varma; Chris H Wiggins; Michael P Sheetz; Dan R Littman; Michael L Dustin
Journal:  Cell       Date:  2007-05-18       Impact factor: 41.582

8.  The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells.

Authors:  Michel H Maillard; Vinicius Cotta-de-Almeida; Fuminao Takeshima; Deanna D Nguyen; Pierre Michetti; Cathryn Nagler; Atul K Bhan; Scott B Snapper
Journal:  J Exp Med       Date:  2007-02-12       Impact factor: 14.307

9.  WASP regulates suppressor activity of human and murine CD4(+)CD25(+)FOXP3(+) natural regulatory T cells.

Authors:  Francesco Marangoni; Sara Trifari; Samantha Scaramuzza; Cristina Panaroni; Silvana Martino; Luigi D Notarangelo; Zeina Baz; Ayse Metin; Federica Cattaneo; Anna Villa; Alessandro Aiuti; Manuela Battaglia; Maria-Grazia Roncarolo; Loïc Dupré
Journal:  J Exp Med       Date:  2007-02-12       Impact factor: 14.307

10.  Wiskott-Aldrich syndrome protein deficiency in B cells results in impaired peripheral homeostasis.

Authors:  Almut Meyer-Bahlburg; Shirly Becker-Herman; Stephanie Humblet-Baron; Socheath Khim; Michele Weber; Gerben Bouma; Adrian J Thrasher; Facundo D Batista; David J Rawlings
Journal:  Blood       Date:  2008-08-07       Impact factor: 22.113

View more
  8 in total

Review 1.  Wiskott-Aldrich Syndrome at the nexus of autoimmune and primary immunodeficiency diseases.

Authors:  Sophia Y Cleland; Richard M Siegel
Journal:  FEBS Lett       Date:  2011-10-25       Impact factor: 4.124

2.  Autoimmunity in wiskott-Aldrich syndrome: an unsolved enigma.

Authors:  Marco Catucci; Maria Carmina Castiello; Francesca Pala; Marita Bosticardo; Anna Villa
Journal:  Front Immunol       Date:  2012-07-18       Impact factor: 7.561

Review 3.  Actin cytoskeletal defects in immunodeficiency.

Authors:  Dale A Moulding; Julien Record; Dessislava Malinova; Adrian J Thrasher
Journal:  Immunol Rev       Date:  2013-11       Impact factor: 12.988

Review 4.  Signal Integration during T Lymphocyte Activation and Function: Lessons from the Wiskott-Aldrich Syndrome.

Authors:  Vinicius Cotta-de-Almeida; Loïc Dupré; Delphine Guipouy; Zilton Vasconcelos
Journal:  Front Immunol       Date:  2015-02-09       Impact factor: 7.561

5.  Lentiviral-mediated gene therapy restores B cell tolerance in Wiskott-Aldrich syndrome patients.

Authors:  Francesca Pala; Henner Morbach; Maria Carmina Castiello; Jean-Nicolas Schickel; Samantha Scaramuzza; Nicolas Chamberlain; Barbara Cassani; Salome Glauzy; Neil Romberg; Fabio Candotti; Alessandro Aiuti; Marita Bosticardo; Anna Villa; Eric Meffre
Journal:  J Clin Invest       Date:  2015-09-14       Impact factor: 14.808

6.  Age-Dependent Defects of Regulatory B Cells in Wiskott-Aldrich Syndrome Gene Knockout Mice.

Authors:  Tadafumi Yokoyama; Ayumi Yoshizaki; Karen L Simon; Martha R Kirby; Stacie M Anderson; Fabio Candotti
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

7.  In Vivo Chronic Stimulation Unveils Autoreactive Potential of Wiskott-Aldrich Syndrome Protein-Deficient B Cells.

Authors:  Maria Carmina Castiello; Francesca Pala; Lucia Sereni; Elena Draghici; Donato Inverso; Aisha V Sauer; Francesca Schena; Elena Fontana; Enrico Radaelli; Paolo Uva; Karla E Cervantes-Luevano; Federica Benvenuti; Pietro L Poliani; Matteo Iannacone; Elisabetta Traggiai; Anna Villa; Marita Bosticardo
Journal:  Front Immunol       Date:  2017-05-02       Impact factor: 7.561

Review 8.  Higher Incidence of B Cell Malignancies in Primary Immunodeficiencies: A Combination of Intrinsic Genomic Instability and Exocytosis Defects at the Immunological Synapse.

Authors:  Jérôme Mastio; Mezida B Saeed; Hannah Wurzer; Max Krecke; Lisa S Westerberg; Clément Thomas
Journal:  Front Immunol       Date:  2020-11-09       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.